In case you missed it: March 28 to April 1
A look at what the Contemporary Pediatrics team covered this week.
This week’s top articles included:
Was the Delta spike in pediatric cases linked to more severe illness?
Was the spike in pediatric cases during the Delta wave of COVID-19 linked to an increase in severe illness? A report offers some answers.
Dana Suskind, founder and co-director of the TMW Center for Early Learning + Public Health, Director of the Pediatric Cochlear Implant Program, and professor of Surgery and Pediatrics at the University of Chicago in Illinois, discusses her new book, published by Dutton/Penguin, focused on how parents can raise children who are well-developed in their cognitive and socioemotional skills.
How parents and teens address mental health concerns
Mental health concerns for children have been greatly exacerbated by the pandemic. A new poll asked parents about their experiences with their teenager’s mental health.
Looking at race and ethnicity in clinical trials
Creating a heterogenous cohort in pediatric clinical trials aids in the generalizing of the results and helps ensure that data of efficacy and safety are more accurate. A report looks at data from the past 10 years to see how often race/ethnicity are reported and whether there has been improved inclusion of non-White children.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
